Articles
5,923 Articles
Psychedelic Invest
/
Nov 27, 2023
Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has signed a Letter of Intent (“LOI”) with Seyltx Inc. (“Seyltx”), a privately owned...
DMT
Psychedelic Spotlight
/
Nov 24, 2023
The Biggest Psychedelic News This Week: November 20th-24th
Psilocybin use shows reduced psychological distress in individuals with adverse childhood experiences, while microdosing shows a "both and" approach to treating ADHD.
Psilocybin
Psilocybin Alpha
/
Nov 24, 2023
Pα+ Psychedelic Patent Analysis (October 2023)
Written by Psychedelic Alpha’s Noah Smith with support from Editor-at-Large and patent attorney Graham Pechenik of Calyx Law.Our monthly Psychedelic Patent Analysis provides headline figures regarding published psychedelic patent applications and grants, before diving into commentary on a select...
Psychedelics Today
/
Nov 24, 2023
PT463 – Bringing Intention, Ceremony, and Inner Healing Intelligence to Modern Medicine
In this episode, Joe interviews Dana Lerman, MD: a decade-long infectious disease consultant who has since been trained in psychedelic-assisted therapy, ecotherapy, and Internal Family Systems, and is the Co-Founder of Skylight Psychedelics, where she prescribes IM ketamine and trains therapists who...
DoubleBlind Mag
/
Nov 23, 2023
2C-I Unveiled—From Research Chemical to Party Psychedelic
2C-B. DiPT. 4-AcO-DMT. When it comes to the names of novel psychedelic compounds, it sometimes feels like all that’s missing is an “H-I-J-K-L-M-N-O-P.” These new compounds are “research chemicals” or “designer drugs.” Their letter and number names represent the arrangement of atoms in...
LSD
DoubleBlind Mag
/
Nov 22, 2023
The 21st Century Witch Has Emerged from the Shadows and Into Our Consciousness
The rise of the witch archetype, both in modern culture (and in its initial incarnation as medieval-era paganism), coincides directly with eras rife with patriarchal suppression, religious extremism, and moral repression. As the cauldron of inequities boils, the witch mounts their broom and rides...
Vice
/
Nov 22, 2023
The Israelis and Palestinians Doing Ayahuasca Together
When Hamas militants went on a vicious rampage in early October and killed more than 1,200 people, Israel retaliated with overwhelming force. Gaza was pummelled with air strikes and invaded by land, with over 11,000 Palestinians killed. Despite the recent announcement of a four-day ceasefire, it is...
Ayahuasca
Psychedelic Spotlight
/
Nov 22, 2023
Stacking Psychedelic Microdoses with ADHD Medication? New Study Hints “Both And” Could Work
A new study exploring real-world psychedelic microdosing for ADHD could help reimagine the way we perceive and treat the condition.
Psychedelics Today
/
Nov 22, 2023
Explore Kanna: A Legal Psychoactive Plant Ally in Turbulent Times
Dive into the world of Kanna with two prominent leaders in the field of plant medicine, Joe Moore, Founder of Psychedelics Today, and Stephanie Wang, Founder and CEO of KA Empathogenics. In this live webinar they will unveil the extraordinary benefits of Kanna, shedding light on what it is, how to...
Psychedelics
Psychedelic Invest
/
Nov 21, 2023
Clearmind Medicine Announces 1-for-30 Reverse Share Split
Following the reverse share split, the Company will have 607,381 Ordinary Shares issued and outstanding Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to...
Psychedelics Today
/
Nov 21, 2023
PT462 – Touch Therapy, Wearable Technology, and Treating Trauma with Safety
In this episode, Joe interviews neuroscientist, board-certified psychiatrist, health tech entrepreneur, inventor, and Co-Founder & Chief Medical Officer at Apollo Neuro: Dr. Dave Rabin, MD, Ph.D. He talks about his path to psychiatry; his realization that trauma and chronic stress were primary...
Reality Sandwich
/
Nov 21, 2023
Burlington’s Massive Psychedelic Mushroom Bust: A Setback or a Wake-Up Call for the Psychedelic Movement?
In a quiet Burlington neighborhood, a substantial psychedelic mushroom operation, valued at around $8.5 million, was recently uncovered. The arrest of 21-year-old Weston Soule has sent shockwaves through the community and broader psychedelic culture. Soule was apprehended for operating an extensive...
Psychedelic Invest
/
Nov 21, 2023
Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development
Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, provides an update on the development of a next generation...
Psychedelics - Green Market Report
/
Nov 21, 2023
Massachusetts Psychedelics Legislation Runs into Trouble
Campaign organizers in Massachusetts may have violated signature-gathering regulations and potentially invalidated thousands of signatures in their quest to legalize psychedelics in the state, according to nonprofit news organization WBUR. “We are working diligently to ensure we meet the...
MDMA
Psychedelics
Psychedelic Spotlight
/
Nov 21, 2023
How Psychedelics Changed My Relationship With Myself
This experience fueled a complete shift and caused me to change my thoughts, my habits, and my life. I am very fortunate to have had my awakening and already find myself in a loving marriage and a career I consider part of my life’s purpose.
Psychedelics
Psychedelic Invest
/
Nov 21, 2023
Silo Pharma Enters into Exclusive License Agreement with Medspray Pharma BV for Intranasal Technology used in SPC-15 Treatment for PTSD
MedSpray’s patented nose-to-brain intranasal technology selected for SPC-15 drug delivery Exclusivity covers multiple indications including anxiety disorders, Alzheimer’s disease, and anorexia Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company”), a developmental stage...
Psychedelic Invest
/
Nov 20, 2023
Psyence Group Announces Resignation of Board Member
Psyence Group Inc. (CSE:PSYG) (“Psyence” or the “Company”), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing announced today that Mr. Marvin Singer has resigned from his position as a Non-Executive Director...
Psychedelics - Green Market Report
/
Nov 20, 2023
New Report Predicts Psychedelic Industry Shakeout
A new report from Water Tower Senior Research Analyst Robert Sassoon predicts a continued sector shakeout in the psychedelics market. Sassoon believes there will be an ongoing consolidation in the industry and that there will be a significant reduction in the number of publicly traded psychedelic...
MDMA
Psychedelics
Psilocybin Alpha
/
Nov 20, 2023
Pα+ Mini Interview with Ester Kincová and Steve Rolles: Regulating the Non-Medical Use of Psychedelics
In last week’s policy-focused Bulletin (149) we covered the publication of Transform Drug Policy Foundation’s 124-page guide, How to Regulate Psychedelics. Shortly after its publication, we spoke to co-authors Steve Rolles and Ester Kincová to better understand their perspectives on emergent...
Psychedelics
Psychedelic Invest
/
Nov 20, 2023
Optimi Health November 2023 Shareholder Update
Dear Optimi Health Shareholders, We greatly appreciate your patience and unwavering support as we navigate the intricate landscape of building and expanding our psychedelic supply enterprise. Throughout 2023, our primary focus has remained centered in Princeton, British Columbia, Canada, operating...
Psilocybin
MDMA
Reality Sandwich
/
Nov 20, 2023
Magic Mushroom Dosage Guide: Microdosing to Heroic Doses
Magic mushrooms, with their enigmatic allure, have fascinated humanity for centuries. These fungi, rich in psilocybin, hold the potential for profound experiences. However, navigating the realm of magic mushrooms requires a nuanced understanding of dosage. This guide covers everything related to...
Psychedelic Invest
/
Nov 20, 2023
Cybin to Host CYB003 Topline Depression Study Review and R&D Briefing on November 30, 2023, in New York City
– Company speakers include Doug Drysdale, Chief Executive Officer; and Amir Inamdar, MBBS, DNB (Psych), MFPM, Chief Medical Officer – – Featured key opinion leaders include Dr. Maurizio Fava, M.D., Massachusetts General Hospital and Harvard Medical School; and Dr. Gitte Moos Knudsen,...
DMT
Psychedelics
Psilocybin Alpha
/
Nov 20, 2023
Pα+ Mini Interview with Eddie Jacobs: Post-Trial Provisions in Clinical Psychedelic Research
In our coverage of the inaugural meeting of the MEP Action Group for the Medical Use of Psychedelics, we discussed the challenging experience faced by a psilocybin trial participant after the support provided by the study’s protocol came to an end. On the very same day that the participant’s...
Psychedelic Invest
/
Nov 19, 2023
FSD Pharma Announces Distribution Date for Distribution of Celly Shares Pursuant to Plan of Arrangement
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company“), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that, further to its press release dated November 7, 2023, that its distribution...
Psychedelic Invest
/
Nov 19, 2023
Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance
As part of the Company’s plan for recompliance, the Company’s shareholders approved a reverse stock split on November 14, 2023. Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel...
Psychedelics Today
/
Nov 17, 2023
Harming While Healing?: The Oppressive Nature of Psychedelic-Centric Drug Policy
Amidst the fervent cries of psychedelic-centric victory heard around Colorado since the passing of the Natural Medicine Health Act (NMHA), it is important to remember those less publicized, less well-funded, and less white, human beings who continue to suffer and die from various manifestations of...
DoubleBlind Mag
/
Nov 17, 2023
Meet the Panther Cap—One of the Strongest Amanitas Around
The Fly Agaric (Amanita muscaria) mushroom carries significant cultural mystique. It’s one of the most recognizable mushrooms and also one of the most well-known entheogens. Entire books delve into the various theories about its use and the subsequent cultural implications. Even children’s...
Psilocybin
Psilocybin Alpha
/
Nov 17, 2023
Pα+ Psychedelic Bulletin #149: Worldwide Psychedelic Policy Developments
At over 5,000 words, this policy-focused Psychedelic Bulletin dives deep into a number of recent events including inaugural hearings in the U.S. House, subcommittee meetings and forums, as well as the publication of reports and key changes to major psychedelic policy reform efforts. This issue’s...
Psychedelic Spotlight
/
Nov 17, 2023
The Biggest Psychedelic News This Week: November 13th-17th
Psilocybin can be an useful tool when it comes to reducing nicotine withdrawal, PTSD, and even OCD symptoms. It could also be a hazardous weapon for those who suffer from personality disorders.
Psilocybin
Psychedelics Today
/
Nov 17, 2023
PT461 – Holding Space, Hypnotherapy and Psychedelics, and the Importance of Courage
In this episode of Vital Psychedelic Conversations, David speaks with two current Vital students: Certified Depth Hypnosis Practitioner and Founder and Executive Director of Zoo Labs, Vinitha Watson, CHT; and artist and outdoorsman with decades of experience in bodywork, structural integration, and...
Psychedelic Invest
/
Nov 16, 2023
Psyence Group Announces SEC Effectiveness of F-4 for Proposed Business Combination Between Subsidiary and Nasdaq Listed Newcourt Acquisition Corp
Psyence Group Inc. (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing (“Psyence”), and Newcourt Acquisition Corp (Nasdaq: NCAC) (“Newcourt”), a special purpose acquisition company today...
Psychedelic Invest
/
Nov 16, 2023
PharmaDrug Inc. Completes Debt Restructuring
PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) (“PharmaDrug” or the “Company“), is pleased to announce that it has closed the previously announced debt restructuring (see press release dated November 7, 2023). Under the restructuring, the Company agreed with the holders of its unsecured...
Psychedelic Invest
/
Nov 16, 2023
Federal Court of Australia Approves Incannex’s Re-Domiciliation and Lodgement of Court Orders With ASIC
Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL) (the “Company” or “Incannex”) is pleased to announce that the Federal Court of Australia (“Court”) has today made orders approving the scheme of arrangement in relation to the Company’s proposed re-domiciliation from Australia to...
Psychedelic Invest
/
Nov 16, 2023
Filament Health Announces Third Quarter 2023 Financial Results and Operational Highlights
Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, released its third quarter financial results and operational highlights for the period ended September 30, 2023. “This quarter we have...
Psychedelic Invest
/
Nov 16, 2023
PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules
PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA)(OTCQB:PMBHF), a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo™ MDMA and novel MDXX compounds, and Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament”), a clinical-stage...
MDMA
Reality Sandwich
/
Nov 16, 2023
The Sandwich Showdown: A Lunchtime Odyssey
We have a big appetite for sandwiches at Reality Sandwich. Just as we are evolving consciousness one bite at a time, we’re simultaneously noshing on delicious eats on our lunch breaks. All this hungry curiosity led us to an incredible article titled, The State of the Sandwich: How Do America’s...
